These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2206203)

  • 1. Comparative pathogenicity of a wild-type strain and respiratory mutants of Candida albicans in mice.
    Aoki S; Ito-Kuwa S; Nakamura Y; Masuhara T
    Zentralbl Bakteriol; 1990 Aug; 273(3):332-43. PubMed ID: 2206203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity of 5-fluorocytosine resistant strains of Candida albicans.
    Fasoli MO; Kerridge D; Ryley JF
    J Med Vet Mycol; 1990; 28(1):27-34. PubMed ID: 2194016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic infection following intravenous inoculation of mice with Candida albicans int1 mutant strains.
    Bendel CM; Kinneberg KM; Jechorek RP; Gale CA; Erlandsen SL; Hostetter MK; Wells CL
    Mol Genet Metab; 1999 Aug; 67(4):343-51. PubMed ID: 10444345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans.
    Navarathna DH; Hornby JM; Krishnan N; Parkhurst A; Duhamel GE; Nickerson KW
    Infect Immun; 2007 Apr; 75(4):1609-18. PubMed ID: 17283095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal pathology and spleen cell chemiluminescence of mice infected with a wild-type and a low-virulence mutant of Candida albicans.
    Fromtling RA; Abruzzo GK; Edison A; Manning-Zweerink M
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 May; 268(3):405-15. PubMed ID: 3043983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological consequences of petite mutations in Candida glabrata.
    Brun S; Dalle F; Saulnier P; Renier G; Bonnin A; Chabasse D; Bouchara JP
    J Antimicrob Chemother; 2005 Aug; 56(2):307-14. PubMed ID: 15958498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The yeast to hyphal transition following hematogenous candidiasis induces shock and organ injury independent of circulating tumor necrosis factor-alpha.
    Matuschak GM; Lechner AJ
    Crit Care Med; 1997 Jan; 25(1):111-20. PubMed ID: 8989186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pathogenicity of auxotrophic mutants of Candida albicans.
    Manning M; Snoddy CB; Fromtling RA
    Can J Microbiol; 1984 Jan; 30(1):31-5. PubMed ID: 6370397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis.
    Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogen-activated protein kinase-defective Candida albicans is avirulent in a novel model of localized murine candidiasis.
    Guhad FA; Jensen HE; Aalbaek B; Csank C; Mohamed O; Harcus D; Thomas DY; Whiteway M; Hau J
    FEMS Microbiol Lett; 1998 Sep; 166(1):135-9. PubMed ID: 9741091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinase production and pathogenicity of Candida albicans. II. Virulence for mice of C. albicans strains of different proteinase activity.
    Kondoh Y; Shimizu K; Tanaka K
    Microbiol Immunol; 1987; 31(11):1061-9. PubMed ID: 3328042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium.
    Jayatilake JA; Samaranayake YH; Cheung LK; Samaranayake LP
    J Oral Pathol Med; 2006 Sep; 35(8):484-91. PubMed ID: 16918600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avirulence of Candida albicans FAS2 mutants in a mouse model of systemic candidiasis.
    Zhao XJ; McElhaney-Feser GE; Sheridan MJ; Broedel SE; Cihlar RL
    Infect Immun; 1997 Feb; 65(2):829-32. PubMed ID: 9009352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity of morphological and auxotrophic mutants of Candida albicans in experimental infections.
    Shepherd MG
    Infect Immun; 1985 Nov; 50(2):541-4. PubMed ID: 3902649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal virulence of Candida albicans strains deficient in Tup1-regulated genes.
    Jackson BE; Mitchell BM; Wilhelmus KR
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2535-9. PubMed ID: 17525181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological attributes of colony-type variants of Candida albicans.
    Dutton S; Penn CW
    J Gen Microbiol; 1989 Dec; 135(12):3363-72. PubMed ID: 2699892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of pathogenicity of various Candida albicans and C. stellatoidea strains.
    Okawa Y; Miyauchi M; Takahashi S; Kobayashi H
    Biol Pharm Bull; 2007 Oct; 30(10):1870-3. PubMed ID: 17917253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between Candida albicans epidermolytic proteinase activity and virulence in mice.
    Louie A; Dixon DM; el-Maghrabi EA; Burnett JW; Baltch AL; Smith RP
    J Med Vet Mycol; 1994; 32(1):59-64. PubMed ID: 8207623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of germfree phagocyte oxidase- and nitric oxide synthase 2-deficient mice, defective in the production of reactive metabolites of both oxygen and nitrogen, to mucosal and systemic candidiasis of endogenous origin.
    Balish E; Warner TF; Nicholas PJ; Paulling EE; Westwater C; Schofield DA
    Infect Immun; 2005 Mar; 73(3):1313-20. PubMed ID: 15731028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of strain variation in virulence of Candida dubliniensis and Candida albicans: results of a blinded histopathological study of invasive candidiasis.
    Asmundsdóttir LR; Erlendsdóttir H; Agnarsson BA; Gottfredsson M
    Clin Microbiol Infect; 2009 Jun; 15(6):576-85. PubMed ID: 19604278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.